Published in Annu Rev Med on January 01, 1987
Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut (1991) 2.29
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology (2010) 2.05
Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg (2000) 1.63
DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus. Am J Gastroenterol (2009) 1.08
Clinical and biological implications of the tumor microenvironment. Cancer Microenviron (2012) 0.95
Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus. Dig Dis Sci (2001) 0.95
Time gated fluorescence spectroscopy in Barrett's oesophagus. Gut (2003) 0.87
Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery. Ann Surg (2001) 0.87
The Association between Childhood Overweight and Reflux Esophagitis. J Obes (2010) 0.76
Barrett esophagus: history, definition and etiopathogeny. J Med Life (2014) 0.75
Surgical management of carcinoma of the esophagus. Bull N Y Acad Med (1993) 0.75
Surveillance in Barrett's oesophagus: a personal view. Postgrad Med J (2002) 0.75
Genetic control of the cell division cycle in yeast. Science (1974) 13.83
Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission. N Engl J Med (1983) 7.50
An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology (1993) 5.41
A p53-dependent mouse spindle checkpoint. Science (1995) 4.01
Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun (1974) 3.91
Regulation of mating in the cell cycle of Saccharomyces cerevisiae. J Cell Biol (1977) 3.68
Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol (1988) 3.67
The acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.49
Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet (1999) 3.30
Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet (1994) 3.22
Campylobacter fetus infection in human subjects: association with raw milk. Am J Med (1979) 2.99
The small intestinal mucosa in dermatitis herpetiformis. I. Severity and distribution of the small intestinal lesion and associated malabsorption. Gastroenterology (1971) 2.80
Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol (1995) 2.73
Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis (1975) 2.56
17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci U S A (1996) 2.53
Symposium on pathology of the gastrointestinal tract-Part II. Small intestinal biopsy. Hum Pathol (1975) 2.40
Latent celiac sprue. Gastroenterology (1974) 2.36
Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun (1974) 2.33
Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastroenterol (2001) 2.21
Collagenous sprue--an unrecognized type of malabsorption. N Engl J Med (1970) 2.21
Sprue by any other name. Gastroenterology (1970) 2.21
Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology (1987) 2.15
Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res (2000) 2.13
Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology (1988) 2.06
p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res (2001) 2.06
The histologic spectrum and clinical outcome of refractory and unclassified sprue. Am J Surg Pathol (2000) 2.05
Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med (2000) 2.05
Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology (1992) 2.03
Electron microscopy of the intestine and rectum in acquired immunodeficiency syndrome. Gastroenterology (1985) 1.92
Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol (1986) 1.91
Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR. Genome Res (1999) 1.90
Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest (1989) 1.83
Primary abdominal lymphoma. Presenting manifestation of celiac sprue or complicating dermatitis herpetiformis. Am J Med (1977) 1.82
The small intestinal mucosa in dermatitis herpetiformis. II. Relationship of the small intestinal lesion to gluten. Gastroenterology (1971) 1.79
Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci U S A (1995) 1.75
Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med (1991) 1.67
p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res (1997) 1.67
Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res (1992) 1.65
The quality of care in Barrett's esophagus: endoscopist and pathologist practices. Am J Gastroenterol (2001) 1.63
p53-mutant clones and field effects in Barrett's esophagus. Cancer Res (1999) 1.61
Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest. Mol Cell Biol (1999) 1.56
Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci U S A (1992) 1.56
Cytomegalovirus-associated gastric ulcer. Gastroenterology (1977) 1.53
Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. Proc Natl Acad Sci U S A (1991) 1.53
17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res (1994) 1.52
Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. Cancer Res (1994) 1.49
Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study. Gut (1999) 1.48
Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene (1996) 1.46
Histology of alcoholic hemorrhagic "gastritis": a prospective evaluation. Gastroenterology (1988) 1.44
Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst (1999) 1.44
p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology (1994) 1.43
Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc (1995) 1.41
Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci U S A (1993) 1.40
17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Cancer Res (1991) 1.39
The normal human esophageal mucosa: a histological reappraisal. Gastroenterology (1975) 1.35
Sulfasalazine-induced exacerbation of ulcerative colitis. N Engl J Med (1982) 1.32
Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene (1996) 1.32
Gastric dysplasia and its management. Gastroenterology (1994) 1.27
Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus. Am J Gastroenterol (2000) 1.25
Oestrogen receptor in breast cancer: prognostic studies using a new immunohistochemical assay. Histopathology (1990) 1.24
Genotypic analysis of multiple loci in somatic cells by whole genome amplification. Nucleic Acids Res (1995) 1.24
Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology (1998) 1.24
Collagenous colitis: a study of the distribution of morphological abnormalities and their histological detection. Hum Pathol (1999) 1.22
Duodenal bicarbonate secretion: eradication of Helicobacter pylori and duodenal structure and function in humans. Gastroenterology (1996) 1.22
Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. Cancer Res (1990) 1.20
The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Gastrointest Endosc (1996) 1.19
Dysfunction of the continent ileostomy: clinical features and bacteriology. Gut (1983) 1.14
Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res (1996) 1.14
Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology (1991) 1.11
Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk. Am J Pathol (1988) 1.10
Helicobacter pylori-associated gastric pathology. Gastroenterol Clin North Am (1993) 1.09
High-quality RNA and DNA from flow cytometrically sorted human epithelial cells and tissues. Biotechniques (2002) 1.08
Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc (2001) 1.06
Interobserver agreement and predictive value of endoscopic findings for H. pylori and gastritis in normal volunteers. Gastrointest Endosc (1995) 1.06
Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the Dysplasia Trial in Linxian, China. Cancer Epidemiol Biomarkers Prev (1994) 1.05
The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Cancer (1994) 1.05
Squamous dysplasia and early esophageal cancer in the Linxian region of China: distinctive endoscopic lesions. Gastroenterology (1993) 1.04
Multiple keratoacanthomata. A unique case and review of the current classification. Acta Derm Venereol (1978) 1.04
Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.04
Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study. Lab Invest (1989) 0.99
Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res (1991) 0.99
Impact of composting strategies on the treatment of soils contaminated with organic pollutants. Environ Pollut (2001) 0.99
Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterology (1987) 0.98
Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms. Ann Intern Med (1975) 0.97
Barrett's esophagus: a model of human neoplastic progression. Cold Spring Harb Symp Quant Biol (1994) 0.97
Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China. Cancer Epidemiol Biomarkers Prev (1994) 0.97
Endoscopic biopsy technique for acquiring larger mucosal samples. Gastrointest Endosc (1991) 0.97
Persistent clonal areas and clonal expansion in Barrett's esophagus. Cancer Res (1992) 0.97
Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium. Gastroenterology (1989) 0.97
Biomarkers in Barrett esophagus. Mayo Clin Proc (2001) 0.97
Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development. Am J Gastroenterol (1992) 0.95
Waist-to-hip ratio, weight gain, and dietary and serum selenium are associated with DNA content flow cytometry in Barrett's esophagus. Nutr Cancer (2000) 0.94
Simultaneous visualization of two antigens in the same tissue section by combining immunoperoxidase with immunofluorescence techniques. J Histochem Cytochem (1979) 0.93
Association of infection due to Helicobacter pylori with specific upper gastrointestinal pathology. Rev Infect Dis (1991) 0.93
Cytomegalovirus infection of the gastrointestinal tract in a patient with late onset immunodeficiency syndrome. Gastroenterology (1977) 0.93
Barrett's esophagus in childhood. Gastroenterology (1985) 0.92
Subepithelial hemorrhages and erosions of human stomach. Dig Dis Sci (1988) 0.91
Artificial antigens. Antibody preparations for the localization of Lewis determinants in tissues. Biochemistry (1981) 0.90
The prevalence of colonic neoplasia in patients with Barrett's esophagus: prospective assessment in patients 50-80 years old. Am J Gastroenterol (1997) 0.90
Application of a luminescence-based biosensor for assessing naphthalene biodegradation in soils from a manufactured gas plant. Environ Pollut (2009) 0.90